3654 results for «600»
3654 results
Treatment of atherosclerotic vasospastic plaque in proximal left anterior descending and left main
17 May 2022 – From EuroPCR 2022
Discover the case of a 57 year-old male patient presenting with chest pain, ECG-ST segment depression in all precordial leads and elevated HS troponins. He already suffered from this event 2 years ago (treated conservatively). Angiogram reveals a vasospastic atherosclerotic plaque in proximal LAD and LM....
New insights in coronary artery disease and OHCA
17 May 2022 – From EuroPCR 2022
Consult this session to gain insights into coronary artery disease and OHCA: learn about the 4-year clinical outcomes of the RESTORE SVD trial regarding the Restore DCB, the results of the FAVOR III trial comparing QFR-guided vs angiography-guided PCI in patients with MVD, and more!
Peripheral Interventions
17 May 2022 – From EuroPCR 2022
Watch this video to learn more about the rationale, design and status of the SirPAD phase III randomized controlled trial, investigating whether the use of sirolimus-coated balloon catheters in patients with peripheral artery disease is not inferior to that of uncoated balloon catheters for major clinical...
Innovative solutions in complex coronary lesions - Part 1
18 May 2022 – From EuroPCR 2022
Consult this session to discover some innovative solutions in complex coronary lesions, such as: revascularisation for a case with ULMCA and RCA calcification CTO, stentless treatment for left main quadrifurcation lesion, OCT-guided PCI with intravascular lithotripsy in a calcified SVG, and more!
Innovative solutions in complex coronary lesions - Part 2
18 May 2022 – From EuroPCR 2022
Consult this session to learn about innovative solutions in complex coronary lesions, thanks to a variety of cases such as: PCI in a patient with absolute contraindication to contrast administration, another kiss in bifurcation, unexplained hypotension and a new mass, and more!
Innovative solutions in complex coronary lesions - Part 3
18 May 2022 – From EuroPCR 2022
Watch these videos to discover some innovative solutions in complex coronary lesions, thanks to a selection of cases: a 27-year-old woman with STEMI and multiple culprit lesions, an unusual communication between aorta and the heart, CTO RCA done with retrograde approach with reverse CART technique, and more!
CTO PCI in images and case examples: what is new in 2026?
07 Jul 2026
Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
